🇺🇸 FDA
Patent

US 8697348

Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571

granted A61PA61P35/00

Quick answer

US patent 8697348 (Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571) held by The Regents of the University of California expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P35/00